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I n t r o d u c t i o n
Malaria is transmitted from man to mos quito through gametocytes that develop in the blood of infected patients and are taken up by the female mosquito when taking a bloodmeal. Gametocytes o f Plasmodium falciparum synthesize molecules of appar ent Mv on SDS-PAGE of 230 and 48/45 kDa (Pfs230 and Pfs48/45), which rem ain ex posed on the surface of macrogametes and zygotes (Vermeulen et al 1985 K u mar and Carter 1984) . These molecules and a surface molecule of apparent Mr of 25 kDa (Pfs25) presented on developing zy gotes, retort cells, and ookinetes are the targets of mAbs some of which can block the subsequent differentiation of the sexual stages in the mosquito; this is defined as tra n sm issio n -b lo c k in g (TB) im m unity (Rener et a i Vermeulen et al. 1985«; Quakyi et al. 1987) . TB antibodies are found in sera from people exposed to natu ral malaria and are-at least in part-asso ciated with immunoglobulin reactivity of these sera (Meuwissen et ai 1985; Mulder et a i 1993).
The conventional bioassay of TB activity is based on development of oocysts in mos quitoes after membrane feeding of gametocytes as described by Vermeulen et a i (1985«) . It is a costly, labor-intensive as say, thus limiting the number of sera that can be tested. Development of a serological test predicting TB activity would greatly simplify the study of the significance of TB immunity. A num ber of studies indicate that antibody responses to epitopes of Pfs48/45 and Pfs230 are part of the response observed after several malaria episodes (Graves et al. 1988 , 1990 Carter et al. 1989) and that some epitope regions are con served in many isolates (Foo et a i 1991). Immunoprécipitation with sera from people living in endemic areas precipitated radioiodinated Pfs48/45 and Pfs230. In Papua New Guinea sera there was a good correla tion between TB activity and antibody re sponse to I25I~labeIed Pfs23Q, although no such correlation was found for Pfs48/45 an tibody reactivity (G raves et al. 1988 ), Among the Sri Lanka sera no correlation was found between TB activity and the presence of antibodies to Pfs230 as de tected by immunoprécipitation of radioiodinated gamete proteins (Premawansa et al. 1994 ).
In the present study a Pfs230-enriched fraction from gametocytes was used for the production of anti-Pfs230 mAbs and devel opment of ELIS As. Competition ELIS As using different H R PO labeled mAbs, immunoprecipitation, and W estern blot anal ysis were developed to characterize anti body reactivity to various epitopes of Pfs230 in sera collected from gametocyte carriers. R eactivity in the competition ELISA was compared to TB activity in the bioassay to analyze a possible predictive value of the competition E LISA for TB ac tivity.
M a t e r ia l s a n d M e t h o d s

Parasites
Mature gametocytes of P.falcipam m (isolate NF54) were produced in an automated large-scale culture system as described by Ponnudurai et al. (1982) . Ma ture gametocytes were isolated at 37°C to prevent ga* metocyte activation as follows. Parasite culture was diluted 10-fold in M199 containing 0.1% glucose (M199-G). After centrifugation for 15 min at 2O0G# the pelleted parasites were resuspended in M199-G, loaded on a cushion of 18% Nycodenz, and centri fuged for 30 min at 5000# as described by Vermeulen et al, (1985«) . The purified gametocytes were used (a] directly, for SIFA, (b) allowed to exflagellate to collecl macrogametes and zygotes for use as dried antigen in IFA, or (c) stored at ~70°C until used for extraction of Pfs230, Macrogametes and zygotes were purified and used for surface radioiodination and immunoprecipitation as described by Vermeulen et a l (1985#).
The Pfs230-Enriched Aqueous Phase (AP) Extract of Gametocytes
Gametocytes suspended in 140 mM N H 4C1 in 10 m M Tris/HCl (pH 7.4) were incubated on ice for 5 min to lyse the erythrocyte membrane and parasites were pelleted by centrifugation (5 min, 16,000# at RT). Par asites were solubilized in 2% TX-114 in a 10 mM Tris/ HC1 buffer (pH 7.4) containing 1 mM PMSF at 4°C as described by Bordier (1981) and Kumar (1985) . The AP and detergent phase (DP) obtained by this method were collected separately. The AP (Pfs23Q-enriched antigen) was dialyzed against 0.1 M N H 4H C 0 3 and freeze-dried in aliquots equivalent to 2 x 107 gameto cytes.
Sera
Field sera, A total of 46 sera was collected from gametocyte carriers (aged between 6 and 36 years) recruited at a dispensary in Yaounde, Cameroon (Tchuinkam et al. 1993) .
Positive control. Serum of a Dutch expatriate who worked in an endemic malaria area in Tanzania for more than 30 years (Stl). This serum was positive in all tests used.
Negative control. A panel of individual serum sam ples and a pooled sample of these sera (N56) were obtained from Dutch bloodbank donor volunteers, with no previous history of malaria.
Complement. Freshly obtained AB blood from Dutch bloodbank donors with no previous malaria ex posure was allowed to clot at room temperature for 1 h and aliquots of the pooled serum were stored at -70°C until required. Freshly thawed samples were used as a source of complement.
Rabbit a-PLL serum. Rabbit anti-poly-L-lysine se rum was a gift from Dr. P. Rotmans, Laboratory of Parasitology, University of Leiden, The Netherlands.
Monoclonal Antibodies
The Pfs230-specific mAb 28F1 has been described by Vermeulen et al, (1985a Vermeulen et al, ( , 1986 . MAb 18F25 was produced and characterized as described by Ver meulen et ai. (1985a) . MAbs 11E3, 12F10, 4H2, 12B3, and 14G8, all reacting with Pfs230, were a kind gift of Dr. R. Carter, Division of Biological Sciences, Edin burgh, England.
For the preparation of new mAbs freshly isolated aqueous phase from a TX-114 extraction (AP), equiv alent to 2 x 107 parasites in 50 jj.1 PBS, was emulsified in 50 jxl Freund's complete adjuvant and injected intraperitoneally in BALB/c mice. The mice were boosted twice with AP in Freund's incomplete adju vant. Serum samples were tested by ELISA (see be low) and on Western blots with gametocyte proteins. Mice were killed 3 days after the last boost, spleen cells were fused with myeloma cells (P3/X63-Ag8.653), and suitable hybridomas were selected as described in more detail by Vermeulen et al. (1985a) . The supernates were screened by antibody reactivity in (a) an IFA using air-dried sexual stage parasites, (b) SIFA and (c) a one-site ELISA using AP as antigen (see below). Positive wells were cloned twice by limiting dilution and further tested on Western blots and by immunoprécipitation (see below). Selected clones were further expanded and ascitic fluids were pro duced. TB activity of ascitic fluid or its purified IgG preparations was determined in the bioassay (see be low).
Purification of Monoclonal Antibodies
Ascitic fluid was defatted with silicon dioxide (Sigma S-5631) as described by Neoh et a i (1986), the immunoglobulin (Ig)-containing supernate was dia-lyzed against 0 .1 M NH4H C 0 3 and freeze-dried in bot tles or IgG was fu rth er purified using a semiautomated FPLC system (Pharmacia) equipped with a Protein A column (Pharmacia). The IgG preparation was mixed with buffer A (0.1 M Tris/HCl + 1.0 M Na2S 0 4, pH 8.0) loaded on the column at a flow rate of 1 ml/min and washed with buffer A for 8 min. Subse quently, buffer B (0.1 M glycine/HCl, pH 2.5) was added to obtain a gradient of 5 to 50% B in 15 min followed by elution with 100% B for 5 min. The IgGcontaining fractions were pooled, dialyzed against 0.1 M NH4H C 03, and aliquots stored freeze-dried in bot tles. All IgG subclasses including IgGl can be recov ered under these conditions.
Surface Immunofluorescence Assay
SIFA was performed with live macrogametes and zygotes. All incubations were done at 50 pd FCS for 15 min (for activation and exflagellation). A 50-jjlI anti body test sample was added and incubated for 15 min. After washing with PBS, the cells were incubated with 50 ( j l I FITC-conjugated goat anti-mouse IgG (Cappel 55493) diluted in PBS with 0.05% Evans blue for 10 min. After two PBS washings, the cells were examined under a cover glass with vaseline-coated edges on a Leitz Ortholux fluorescence microscope (500 x magni fication).
Transmission-Blocking Assay
A bioassay, using membrane feeders to feed A. gambiae mosquitoes, was used to determine TB ca pacity of serum samples (Vermeulen et aL 1985a; Ponnudurai et al. 1987 Ponnudurai et al. » 1989 . All samples were separately tested in the presence of active or inactivated comple ment; all measurements were repeated at least once. Field sera were diluted 3-fold and mAbs or IgG prep aration of the sera 10-fold with negative human serum. Twenty mosquitoes per feeder were dissected 7 days after feeding, the number of oocysts on the stomach wall was counted and William's mean (adjusted geo m etric m ean (GM)) o o cy st n u m b er c a lc u la te d (William, 1937 ). An experiment was considered suc cessful if at least 90% of the mosquitoes of the controls carried oocysts. The adjusted GM was used to deter mine the reduction activity (R) according to the equa tion
where Tx is the geometric mean for the test feeder and Tc is the geometric mean of three controls. Because of assay variation only values over 85% 18 ROEFFEN ET AL.
were considered to be a positive transmission-blocking result.
Immunoprecipitation
Macrogametes and zygotes were surface radioiodinated by catalyzed iodination (isotope I25iodine), sol ubilized by NP-40, and the extract was used for indi rect immunoprecipitation as described by Vermeulen et al. (1985a) ,
Labeling of the mAbs with HRPO
Labeling of FPLC-purified mAb with HRPO was performed using the periodate method with an input molar HRPO/IgG ratio of 4 according to Wilson and Nakane (1978) . The labels were dialyzed against PBS, supplemented with thimerosal (0.01%) and FCS (1%), and the samples freeze-dried in bottles and stored at 4°C.
Enzyme-Linked Immunosorbent Assays
I, Detection of Pfs230. (a) Microtiter plates were coated with PLL, washed with PBS, and incubated with serial dilutions of AP in PBS. Subsequently, free PLL binding sites were blocked by incubation with 0.2 mg/ml rabbit a-poly-L-lysine Ig in PBS for 30 min. Fol lowing three washes with PBS, the wells were incu bated with 50 fil HRPO-labeled anti~Pfs230 mAb (2 jxg/ml) for 2 hr, After a washing step, plates were in cubated with 60 jil TMB (0.25 mAi 3 ,3 \5 ,5 'tetramelhylbenzidine, 0.7 mM H20 2, 0,1 M sodiumacetate, pH 5.5) substrate solution for 20 min. The en zyme reaction was stopped by adding 60 |xl 4 N H2S 0 4 and the optical density (QD) was determined on an ELISA reader at 450 nm (Titertek Multiskan MCC/ 340).
(b) Two-site ELISAs were carried out as described by Vermeulen et a i (19856) , Zavala et ai. (1983), and Carter et al. (1985) . Microtiter plates were coated with 50 pi of anti-.Pfs230 mAb (10 jxg/ml) in PBS for 30 min. Plates were washed three times with PBS and satu rated with 5% FCS in PBS. After incubation with AP extract the wells were incubated with HRPO-labeled anti-Pfs230 mAbs, substrate and the absorbance read at 450 nm as above.
IL Competition ELISAs. Pfs23Q was captured from AP extract in microtiter plates as described above un der la or lb. After three washes with PBS, wells were incubated with a mixture of 30 fil test sample and 30 jxl HRPO-labeled anti-Pfs23G mAb for 2 hr. Competition ELISAs were carried out using serial twofold dilutions of unlabeled anti-Pfs230 mAbs (ranging from 31 to 4000 ng/ml) or human sera (ranging from 1/10 to 1/640) made up in PBS containing 0.1% FCS. The plates were washed, incubated with substrate, and the absorbance was read at 450 nm as above.
All incubations were carried out at room te x ture. The competition titer is defined as the dilute the test serum that results in the same OD reading * ■ the (competition negative) control serum. Sera »ill titer > 1/20 are considered positive.
Comparison of the TB Assay and Competition ELISA for Sera
The results of competition ELISAs and the bioa$<were compared by a statistical test on agreement^kappa as the index of observed agreement (Landisr Koch 1977; Altman 1991) . The index kappa (kH: calculated from the observed and expected (ctai, distribution) frequencies on the diagonal of the 2 r table of outcomes of the bioassay and ELISA Table IV ). The approximate standard error ofjck
where P0 is observed proportional agreement and Pri the expected proportional agreement by chance. 1 approximate 95% confidence interval is given by k: 1.96 SE(k), The index of agreement k has a maxims: 1,00 when agreement is perfect, a value of zero itic cates no agreement better than chance. Negatived ues indicate disagreement. The guideline by Atom: (1991) was used to determine the strength of agw ment.
RESULTS
Detection and preservation o f Pfs230k gametocyte extracts. Pfs230 was found t( be exclusively present in the AP of the TX -114 e x tra c t which also contained tract am ounts of other protein molecules such a* 27, 16, 48/45 kDa as detected by specific ELISA s and SDS-PAGE analysis (data not shown).
Im m unoreactivity of Pfs230 in the freshlv prepared AP with mAbs 18F25 and 28F1 as determ ined by one-or two-site ELISA or on W estern blot decreased rapidly during further processing and storage. After two cycles of freeze-thawing of a freshly pre pared AP, only 20% immunoreactivity was left with mAb 18F25 and no immu noreac tivity at all with mAb 28F1. Pfs230 detec tion did not change using protein staining on SD S-PA G E gels (data not shown). In addition, immunoreactivity of Pfs230 was lost during freeze-drying in PBS (increased gait c o n c e n tra tio n s gen erated during freeze-drying). Exposure to lOx concen trated PBS or 1 M NH4HCO3 solution led to an instantaneous loss of immunoreactivity in the one-site ELISA. Immune reactiv ity was preserved when AP was dialyzed against 0.1 M N H 4H C 0 3, freeze-dried, and stored at 4°C, Pfs230 immunoreactivity ap peared to be stable for 6 to 8 weeks when stored in vacuo or under N2 gas and only 2 weeks when stored under air or in solution.
Immunoreactivity of anti-Pfs230 mAbs and epitope mapping. All mAbs including the newly developed 63F2A2 (IgG2a), 63F3C8, and 63F6D7 (both IgGl) as well as 18F25, 28F1, 4H2, 12B3, and 14G8 (all IgGl) and 11E3 and 12F10 (both IgG2a) re acted specifically with air-dried gametocytes and the surface of freshly prepared live intact macrogametes and zygotes. All above mentioned mAbs precipitated Pfs230 of 125I surface radioiodinated gametes (data not shown). On Western blots of NP-40 ex tracts of nonlabeled gametocytes, mAbs 63F2A2, 63F6D7, 12F10, 18F25, and 11E3 recognized proteins of apparent Mr 230 and 260 kDa under nonreducing conditions. The other mAbs (63F3C8, 14G8, 4H2, 12B3, and 28F1) showed no reactivity on W estern blot (see Table I ).
C heckerboard titratio n s w ith various concentrations of labeled mAbs and AP were performed to establish optimal condi tions for Pfs230 detection. Such concentra tions of antigen and HRPO-labeled mAb were chosen so that maximal reduction of the OD was obtained when small amounts of competing antibody were included in the test. Optimal conditions for the competition ELISA were considered to be present with >60% of maximal binding of HRPO -m A b and an OD reading of > 1.0. For mAbs 63F2A2 (0.3 n.g/ml) and 63F6D7 (0.5 ^g/ml) equal concentrations of labeled mAb and the corresponding nonlabeled mAb at the 50% com petition value was found. The HRPO-labeling method did not decrease the affinity of most mAbs. Only with mAbs 28F1 (1.0 versus 0.1 |JLg/ml) and 63F3C8 (2.5 versus 0.25 (xg/ml) was considerably less of the nonlabeled, corresponding mAb needed for 50% competition, suggesting that the immunoreactivity of these mAbs was sub stantially reduced after labeling.
The epitope specificity of each mAb was determined by (a) using different capture and labeled mAbs in two-site ELISA s and (b) competition between labeled mAbs and various unlabeled mAbs in one-site compe tition ELISAs. None of the labeled mAbs bound to Pfs230 when captured by the cor responding nonlabeled mAbs. The results with both systems (Tables I and II) suggest the presence of five distinct epitopes or epitope regions with two exceptions; (a) when 12F10 was used to capture Pfs230 no reaction with any of the labeled mAbs could be found, w hereas 12F10 reacted with Pfs230 captured by several other mAbs. This may indicate that coated mAb 12F10 cannot capture Pfs230. (b) Competi tion between mAbs was independent of the use of the mAb in labeled or unlabeled form, except for 63F2A2. In the one-site ELISA , 63F2A2 com peted with labeled 28F1, but labeled 63F2A2 did not compete with unlabeled 28F1. This may indicate that 63F2A2 and 28F1 react w ith the same epitope but with a considerable difference in affinity. A tentative map of the five epitope regions is given in Fig. 1 . Transmission-blocking activity of mAbs. Ascitic fluid and/or purified IgG from the hybridomas were included in the transmission-blocking feeder assay in the presence of either active or inactivated complement. Figure 1 shows that 5 |xg of mAbs 11E3, 12F10, and 63F2A2 (all IgG2a) blocked transmission more than 99%, but only in the presence of complement. M Abs 18F25, 63F6D7, 63F3C8, 4H2, 12B3, 28F1, and 14G8 (all being IgGl) did not reduce trans m ission irrespective of the presence of com plem ent. Thus, epitope analysis and transm ission-blocking experim ents show that both blocking and nonblocking mAbs reacted with the same epitope and also compete for binding to that epitope. Trans mission-blocking activity correlates with the p resen ce of the com plem ent fixing IgG2a isotypes which are only available for two epitopes (see Fig. 1 ).
Transmission-blocking activity in human field sera, Forty-six sera from gametocyte carriers, heat inactivated at 56°C for 30 min, were tested in feeding experiments in the presence of active and inactivated com plement. Nineteen (41.3%) of these 46 sera consistently blocked transm ission in the presence of complement. Twelve of the 19 sera with a TB activity were retested in the bioassay both in the presence of either ac tive or inactivated complement. None of these 12 field sera showed a complementdependent transm ission-blocking activity (data not shown).
Pfs230-associated TB activity. All 46 These 46 sera w ere further analyzed in a two-site com petition ELISA with 18F25 as capture mAb and HRPO-63F2A2 as label. Figure 2 shows competition by a serial di luted positive (S tl) in comparison to a neg ative serum (N56). The negative serum did not com pete with HRPO-63F2A2 for bind ing to Pfs23Q. The overall interassay vari able in this test (six times tested in dupli cate) has an average deviation of the mean OD at each dilution step of 0.12 (21%). The overall intraassay variation resulted in an average deviation of the mean. Seven dif ferent mAbs reactive to the five epitopes/ regions of Pfs230 described above, includ ing the com plem ent-dependent TB mAbs 11E3 and 63F2A2, were labeled with HRPO to investigate their competition with anti bodies in serum samples of gam etocyte car riers in the two-site competition ELISA . Table III shows that competition-positive human field sera (6 of 46) competed with all lab eled m A bs, i.e ., w ith all e p ito p e s/ regions available, with no exception either in the co m p etitio n -p o sitiv e or negative sera. N o significant differentiation in anti body resp o n ses to the different Pfs230 epitopes was found. Five of these six sera blocked transm ission. Serum 41 (see Table  III ), the only nonblocking serum, reduced sera of gametocyte carriers precipitated a transm ission in a com plem ent-dependent molecule of apparent Mr on SDS-PAGE of 230 kDa from NP-40 extracts of 125I surface
The correlation between the TB activity radioiodinated gametes and reacted with (positive ^85% , negative <85%) and the molecules of apparent Mr of 230 and 260 kDa on a Western blot of NP-40 extracts of Q(63F3C8 TB-(1) 
way.
Pfs230 com petition ELISA is depicted in Table IV . Five (26%) serum samples w ere nonlabeled gametocytes under nonreducing positive in the TB assay and in the compeconditions (data not shown). These results tition ELISA , 14 (30%) were negative in the also showed that the antibodies present in the sera of the gametocyte carriers to n 5Ilabeled Pfs230 precipitated a v ariab le amount of the Pfs230 band. Due to varia tion of the 125I labeling of various batches of parasites used for these analysis our tech-com petition E L ISA but positive in the TB assay, and 26 (56%) were negative in both tests. The index of agreement betw een the outcom es of bioassay and the com petition E L IS A is k = 0.25, 95% confidence inter val -0 .0 6 , + 0.56. The index indicates (Altnique only perm itted a sem iquantitative man, 1991) that agreement is fair to poor analysis and no correlation was found be tween antibody reactivity to l25I-labeled Pfs230 and TB activity, and the negative value in the confidence in terval indicates that agreement can be ex plained by chance. The E L ISA outcom es addition, on SDS-PAGE a protein of appar ent Mr of 260 kDa is also recognized on blots. This difference between results ob tained with immunoprecipitation and West ern blot analysis has been described before (Quakyi et al. 1987) and is best explained by the intracellular localization of a higher Mr precursor of Pfs230. MAbs can also be sub divided by their ability to block transmis sion, i.e., all IgGl mAbs were negative and IgG2a mAbs (11E3, 63F2A2, and 12F10) blocked transmission in a complement-dependent reaction. Complement-dependent lysis of macrogametes and zygotes in vitro by Pfs230 mAbs has been described by Quakyi et al. (1987) and has also been found in the P. gallinaceum system (Kaushal et al. 1983 ).
These mAbs were used for the develop ment of a number of different ELISAs in order to construct an epitope map of Pfs230 (Fig. 1) , to determine the presence of anti-Pfs230 antibodies in field sera and to corre late presence of anti-Pfs230 antibodies in field sera with TB activity of these sera as observed in the bioassay.
The Pfs230 antigen used in these ELISAs was prepared by Triton TX-114 (gameto cyte extraction and phase separation as de scribed by B o rd ier (1981) and K u m ar (1985) . It appeared that immunoreactivity of Pfs230 in these extracts was lost upon storage in PBS solution, after fre e z ethawing, or exposure to high-salt concen tration. The use of aqueous solutions con taining a volatile buffer for freeze-drying and storage in vacuo prevented loss of im m unoreactivity for periods of 2 m onths. Loss of immunoreactivity of Pfs230 after exposure to high-salt concentration has been observed before (Kumar and Wizel, 1992) . The loss of immunoreactivity in so lution suggests th at oxidative changes could be in v o lv e d in c o n fo rm a tio n a l changes of Pfs230. However, storage of AP in the presence of either vitamin E or glutathion did not prevent loss of immunore activity (data not shown).
One-site E L ISA s could not be devel oped by direct coating of Pfs230 to the plates, but was realized by coating on a precoat of poly-L-lysine or Pfs230-specific mAb. The positive charge of poly-L-lysine most probably enables binding with the glutam ate-rich Pfs23G (Williamson et al. 1993 ).
This panel of mAbs enabled the recogni tion of five different epitope regions on the Pfs230 m o le c u le , each e p ito p e b ein g present only once. Monoclonal antibodies allocated to two epitope regions (here des ignated 1 and 2) were able to react on a W estern blot. All mAbs of the complement fixing IgG2a subclass blocked transm is sion, whereas none of the m Abs of the com plement nonfixing IgG l subclass did. Thus, both TB-positive and negative antibodies can bind to the same epitope and com pete w ith one a n o th e r for b in d in g to th a t epitope. MAbs to the three other regions (designated 3 to 5) did not block transm is sion but these were all of the IgG l subclass.
In a panel of sera from gam etocyte carri ers from Cameroon all 46 sera immunoprecipitated Pfs230, and 19 sera exhibited TB activity. Sera were classified with respect to their capacity to im m unoprecipitate Pfs230 by a semiquantitative analysis of au toradiograms; compared to the results of the TB bioassay this revealed no correla tion {P value -0.396). None of 12 sera showing TB activity needed the presence of complement for this activity. M ore sera need to be tested before definite conclu sions can be drawn on the role of comple ment in TB activity of human field sera.
Six sera of these gam etocyte carriers from Cameroon were positive in the com petition ELISA and this was independent of the epitope region analyzed, indicating that there was no epitope restriction. Five of these com petition-positive sera also blocked transmission in the bioassay, but 14 of the 19 blockers were negative in the competition assays.
To compare the outcomes of TB assay and ELISA a statistical test for comparison of proportions or association is not consid ered appropriate. Besides sensitivity and specificity a measure of agreement is re quired rather than association. The index of agreement k measures the amount of agree ment beyond chance and can be used for the correlation analysis. In gametocyte car riers the amount of agreement was fair to poor but since the confidence interval con tains zero, this implies that the agreement can be explained by chance.
In summary, the Cameroon field sera ex hibit (a) absence of complement depen dency of TB activity, (b) reactivity with all available epitopes o f Pfs230 analyzed so far, and (c) no correlation between either the Pfs230 competition ELISA or immuno précipitation of Pfs230 from NP-40 gameto cyte extracts and TB activity as observed in the bioassay. This raises the questio n whether under field conditions TB activity is Pfs230 mediated.
Our results are in contrast to results ob tained in a series of Papua New Guinea sera, where Graves et a i (1988) observed a correlation between im munoprécipitation of Pfs230 and reduction of infectivity to mosquitoes. In our hands all the Cameroon sera precipitated Pfs230 and a semiquanti* tative analysis on autoradiograms revealec no correlation with TB activity. One aspect is the difference in study populations. A parallel study analyzing TB activity and an tibody reactivity against Pfs230 as deter m ined by im m unoprecipitation in a Sn Lanka population failed to show this corre lation (Premawansa et al. 1994) . Our data do not exclude the possibility that Pfs230 mediated TB activity might be present h field sera which are com plem ent indepeiv dent. Another important question is to find out w hether Pfs230-mediated TB activity is always complement dependent.
